Stay updated on Nivolumab in Advanced SqNSCLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Advanced SqNSCLC Clinical Trial page.

Latest updates to the Nivolumab in Advanced SqNSCLC Clinical Trial page
- CheckyesterdayChange DetectedThe page shows Revision: v3.3.4, replacing the previous v3.3.3; this is an admin/version update and does not modify study details or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe Locations section was updated with multiple site additions and removals across Europe and other regions, reflecting updated centers for the study.SummaryDifference2%

- Check51 days agoChange DetectedPublications section now notes that entries are automatically filled from PubMed and may not relate to the study. The revision label updated from v3.2.0 to v3.3.2.SummaryDifference0.3%

- Check58 days agoChange DetectedRemoved the site-wide notice about government funding and NIH Clinical Center operating status, which previously directed users to cc.nih.gov and opm.gov for updates. This change affects informational messaging rather than the study details presented on the page.SummaryDifference0.2%

- Check79 days agoChange DetectedNo additions or deletions detected in the page content. The study page title, identifiers, and key details remain unchanged.SummaryDifference0.2%

- Check101 days agoChange DetectedUpdated version to v3.2.0 and added a government operating-status notice for NIH Clinical Center, directing users to cc.nih.gov and opm.gov.SummaryDifference3%

Stay in the know with updates to Nivolumab in Advanced SqNSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Advanced SqNSCLC Clinical Trial page.